MODERN APPROACHES TO THE TREATMENT OF HYPERCHOLESTEROLEMIA IN CORONARY HEART DISEASE PATIENTS WITH METABOLIC SYNDROME AND CHRONIC NON-ALCOHOLIC STEATOHEPATITIS

MODERN APPROACHES TO THE TREATMENT OF HYPERCHOLESTEROLEMIA IN CORONARY HEART DISEASE PATIENTS WITH METABOLIC SYNDROME AND CHRONIC NON-ALCOHOLIC STEATOHEPATITIS

Aim. To assess safety and effectiveness of combination therapy by simvastatin with ursodezoxycholic acid in treatment of dyslipidemia in coronary heart disease patients.Material and methods. Totally 30 CHD patients (stable angina, 2nd functional class — 2FC) having metabolic syndrome (MS) had combin...

Full description

Bibliographic Details
Main Authors:	M. A. Osadchuk, L. I. Butorova, K. S. Solodenkova, G. M. Tokmulina
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2014-07-01
Series:	Российский кардиологический журнал
Subjects:	ischemic heart disease dyslipidemia obesity fatty liver disease statins ursodezoxycholic acid
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/126

Similar Items

Dyslipidemia: A Trigger for Coronary Heart Disease in Romanian Patients with Diabetes
by: Mihnea-Alexandru Găman, et al.
Published: (2020-05-01)

Differences in achieving treatment goals with statin use in various regions of Poland – 3ST-POL study results
by: Daniel Śliż, et al.
Published: (2015-12-01)

Interrelation of blood lipid spectrum, level of systemic inflammation and mass of body in patients with coronary heart disease in combination with nonalcoholic fatty liver disease and their dynamics in terms of secondary prevention
by: Kuryata O.V., et al.
Published: (2014-11-01)

Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice
by: Han-Sol Park, et al.
Published: (2016-04-01)

Modern principles of atherogenic dyslipidemia management in special groups of patients
by: Marina G. Bubnova, et al.
Published: (2020-09-01)

Lipid profile in different grades of Ultrasonic Non-Alcoholic Fatty Liver Disease
by: Khem Raj Bhusal, et al.
Published: (2017-07-01)

Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable and acute coronary heart disease in the United Arab Emirates
by: Wael Al Mahmeed, et al.
Published: (2019-01-01)

SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION
by: S. N. Bel'diev
Published: (2017-03-01)

EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS
by: D. M. Aronov, et al.
Published: (2016-01-01)

COMPARATIVE EFFICACY OF THE STATINS IN PREVENTING AND TREATING OF THE CORONARY HEART DISEASE
by: S. V. Shalaev, et al.
Published: (2016-01-01)

The Effectiveness of the Influence of Median-Dose StatinTherapy on the Serum Lipid Profilein Patients with Stable Coronary Heart Disease, Combined with Non-Alcoholic Fatty Liver Disease at the Stage of Steatosis
by: Vakalyuk I., et al.
Published: (2018-06-01)

Comparisons between non-alcoholic steatohepatitis and alcohol-related hepatocellular carcinoma
by: Rahul Kumar, et al.
Published: (2020-04-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT DO PRACTICING PHYSICIANS THINK ABOUT IT?
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Lipid Metabolism Profiles in Rheumatic Diseases
by: Weilin Chen, et al.
Published: (2021-04-01)

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I
by: N. M. Akhmedzhanov, et al.
Published: (2015-09-01)

Diet-induced dyslipidemia drives store-operated Ca2+ entry, Ca2+ dysregulation, non-alcoholic steatohepatitis, and coronary atherogenesis in metabolic syndrome
by: Neeb, Zachary P.
Published: (2010)

Knowns and unknowns in the care of pediatric familial hypercholesterolemia
by: Andrew C. Martin, et al.
Published: (2017-09-01)

Association of Lipid Profile with Non-Alcoholic Fatty Liver Disease diagnosed on Ultrasound
by: Ambreen Zahoor, et al.
Published: (2020-12-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
by: "Ebrahimi Daryani N, et al.
Published: (2003-03-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
by: "Ebrahimi Daryani N, et al.
Published: (2003-05-01)

Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study
by: Yuta Yoshimura, et al.
Published: (2021-08-01)

Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease
by: Hamza El Hadi, et al.
Published: (2019-05-01)

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
by: Narges Ashraf Ganjooei, et al.
Published: (2021-05-01)

Hypolipidemic therapy in patients with non-alcoholic fatty liver disease
by: L. B Lazebnik, et al.
Published: (2010-03-01)

Features of Serum Fatty Acids at Acute Ischemic Stroke Onset in Statin-Treated Patients with Hypercholesterolemia
by: Takahisa Mori, et al.
Published: (2020-09-01)

Coronary heart disease and risk factors in elderly population
by: A. E. Imaeva, et al.
Published: (2016-04-01)

Prescription and adherence to statins of patients with coronary artery disease and hypercholesterolemia
by: Mansur Antonio P., et al.
Published: (2001-01-01)

Use of Statins as Lipid Lowering Agent in Hypercholesterolemia in a Tertiary Care Hospital: A Descriptive Cross-sectional Study
by: Aashish Kumar Bhattarai, et al.
Published: (2020-12-01)

Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: Do they differ from obese or overweight non-alcoholic fatty liver disease?
by: Ramesh Kumar, et al.
Published: (2013-01-01)

The “Chinese Dose” of statin
by: Ping Ye
Published: (2016-01-01)

Clinical effeciency of mineral waters in complex treatment of non-alcohol fatal disease liver
by: I. B. Zabolotna
Published: (2018-06-01)

Ways of increasing the efficiency of treatment of patients with non-alcoholic fat liver with liver's disease
by: I. B. Zabolotna
Published: (2017-05-01)

THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA?
by: S. N. Bel'diev
Published: (2016-06-01)

Ductular reaction in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: O. M. Gavrilyuk
Published: (2014-04-01)

Are therapeutic LDL goals justified? Controversies between the European and American guidelines
by: Vicente Bertomeu-Martínez
Published: (2016-12-01)

The use of statin drugs in patients with chronic kidney disease, combined with dyslipidemia
by: D.D. Ivanov, et al.
Published: (2015-04-01)

Approach To Lipid Screening As A Risk Marker For Cardiovascular Disease In Pediatric Patients With Diabetes
by: Jennifer Rachel Law, et al.
Published: (2011-10-01)

New-onset severe hypercholesterolemia in a patient with cholestatic liver disease. Should we treat the lipids?
by: Panteleimon E. Papakonstantinou, et al.
Published: (2017-07-01)

Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective
by: Mohammad Said Ramadan, et al.
Published: (2021-04-01)

Effect of simvastatin on fatty acids composition of erythrocyte membranes in women with chronic form of coronary heart disease
by: A. M. Dygai, et al.
Published: (2013-09-01)